Pharmosa Biopharm (6875) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 國邑*

Pharmosa Biopharm (6875) reported revenue of NT$1.6 million for Oct 2026, -65.3% from the previous month. Revenue for Jan–Oct 2026 was NT$8.2 million (-58.5% year on year).

In Oct 2026, it ranked No. 146 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$112.6 million24/10Dec 2024 NT$4.4 millionMay 2025 NT$15.7 million25/05Jul 2025 NT$4 millionNov 2025 NT$45.6 million25/11Dec 2025 NT$2 millionMar 2026 NT$1.8 million26/03Jul 2026 NT$248,000Aug 2026 NT$3,00026/08Sep 2026 NT$4.6 millionOct 2026 NT$1.6 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$1.6 million—-65.3%
Sep 2026NT$4.6 million—+151,566.7%
Aug 2026NT$3,000—-98.8%
Jul 2026NT$248,000-93.8%—
Jun 2026NT$0——
May 2026NT$0-100.0%—
Apr 2026NT$0—-100.0%
Mar 2026NT$1.8 million——
Feb 2026NT$0——
Jan 2026NT$0—-100.0%
Dec 2025NT$2 million-54.4%-95.6%
Nov 2025NT$45.6 million——
Oct 2025NT$0-100.0%—
Sep 2025NT$0-100.0%—
Aug 2025NT$0—-100.0%
Jul 2025NT$4 million——
Jun 2025NT$0—-100.0%
May 2025NT$15.7 million+64.3%—
Apr 2025NT$0——
Mar 2025NT$0——
Feb 2025NT$0——
Jan 2025NT$0-100.0%-100.0%
Dec 2024NT$4.4 million——
Nov 2024NT$0—-100.0%
Oct 2024NT$112.6 million—+175.4%

Jan–Oct 2026 cumulative: NT$8.2 million (-58.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Pharmosa Biopharm vs PEC / Pharmosa Biopharm vs Lotus Pharm / Pharmosa Biopharm vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

本月營收較去年同期增加,主係L606檢測服務收入及子公司營收所致;累計營收較去年同期減少,主係臨床試驗用藥出貨時點不同所致。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16